Towards microbial fermentation metabolites as markers for health benefits of prebiotics

Nutrition Research Reviews

Volumn 28, Issue 1, 2015, Pages 42-66

  Verbeke, Kristin A ^a   Boobis, Alan R ^b   Chiodini, Alessandro ^c,d   Edwards, Christine A ^e   Franck, Anne ^f   Kleerebezem, Michiel ^g   Nauta, Arjen ^h   Raes, Jeroen ⁱ   Van Tol, Eric A F ^j   Tuohy, Kieran M ^k  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c International Life Sciences Institute of Europe   (Belgium)

^d European Research Council   (Belgium)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f Cargill R D Centre Europe   (Belgium)

^g WAGENINGEN UNIVERSITY   (Netherlands)

^h FRIESLANDCAMPINA   (Netherlands)

ⁱ REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^j Mead Johnson Nutritionals   (United States)

^k RESEARCH AND INNOVATION CENTRE   (Italy)

more..

Author keywords

Metagenome; Microbial metabolites; Nutrikinetics; Prebiotic health benefits

Indexed keywords

2 METHYLBUTYRIC ACID; 3 HYDROXYPHENYLACETIC ACID; 4 HYDROXYBENZOIC ACID; 4 HYDROXYPHENYLACETIC ACID; 8 PRENYLNARINGENIN; ACETIC ACID; AMMONIA; BUTYRIC ACID; CATECHOL; DAIDZEIN; ENTERODIOL; ENTEROLACTONE; EQUOL; HYDROGEN SULFIDE; INDOLE; ISOBUTYRIC ACID; ISOVALERIC ACID; LACTIC ACID; PARA CRESOL; PHENOL; PHLOROGLUCINOL; POLYPHENOL DERIVATIVE; PREBIOTIC AGENT; PROPIONIC ACID; PROTOCATECHUIC ACID; PYROGALLOL; RUTOSIDE; SHORT CHAIN FATTY ACID; SUCCINIC ACID; UNINDEXED DRUG; CARBOHYDRATE; FATTY ACID; POLYPHENOL; PROTEIN; VOLATILE FATTY ACID;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; APPETITE; ARTICLE; CANCER RISK; COLON; CYTOTOXICITY; DIETARY FIBER; DRUG EFFECT; FECES ANALYSIS; FERMENTATION; HUMAN; IMMUNITY; INTESTINE FLORA; LIPID METABOLISM; METABOLITE; METABOLOMICS; METAGENOMICS; NONHUMAN; OBESITY; PROTEIN METABOLISM; ULCERATIVE COLITIS; BACTERIUM; CHEMISTRY; DRUG EFFECTS; FECES; HEALTH PROMOTION; INTESTINE; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; PLANT;

BACTERIA; CARBOHYDRATES; COLON; FATTY ACIDS; FATTY ACIDS, VOLATILE; FECES; FERMENTATION; GASTROINTESTINAL MICROBIOME; HEALTH PROMOTION; HUMANS; INTESTINES; METABOLOMICS; METAGENOMICS; PLANTS; POLYPHENOLS; PREBIOTICS; PROTEINS;

EID: 84942753861     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422415000037     Document Type: Article

References (267)

1. Scott KP, Gratz SW, Sheridan PO, et al. (2013) The influence of diet on the gut microbiota. Pharmacol Res 69, 52-60.
2. Qin JJ, Li RQ, Raes J, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
3. Nicholson JK, Holmes E, Kinross J, et al. (2012) Host-gut microbiota metabolic interactions. Science 336, 1262-1267.
4. Blaut M & Clavel T (2007) Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 137, 751S-755S.
5. Marchesi J & Shanahan F (2007) The normal intestinal microbiota. Curr Opin Infect Dis 20, 508-513.
6. Hooper LV, Littman DR & Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336, 1268-1273.
7. Roberfroid M, Gibson GR, Hoyles L, et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1-S63.
8. Gibson GR & Roberfroid MB (1995) Dietary modulation of the human colonic microbiota-introducing the concept of prebiotics. J Nutr 125, 1401-1412.
9. Mahowald MA, Rey FE, Seedorf H, et al. (2009) Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A 106, 5859-5864.
10. den Besten G, van Eunen K, Groen AK, et al. (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54, 2325-2340.
11. Cook SI & Sellin JH (1998) Review Article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 12, 499-507.
12. Topping DL & Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81, 1031-1064.
13. Freeland KR (2010) Wilson C & Wolever TMS Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103, 82-90.
14. Wolever TMS, Josse RG, Leiter LA, et al. (1997) Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. Metabolism 46, 805-811.
15. Edwards CA, Parrett AM, Balmer SE, et al. (1994) Faecal short chain fatty acids in breast-fed and formula-fed babies. Acta Paediatr 83, 459-462.
16. Knol J, Scholtens P, Kafka C, et al. (2005) Colon microflora in infants fed formula with galacto-And fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40, 36-42.
17. Midtvedt AC (1992) & Midtvedt T Production of short chain fatty-Acids by the intestinal microflora during the 1st 2 years of human life. J Pediatr Gastroenterol Nutr 15, 395-403.
18. Mariat D, Firmesse O, Levenez F, et al. (2009) The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 9, 123.
19. Andrieux C, Membre JM, Cayuela C, et al. (2002) Metabolic characteristics of the faecal microflora in humans from three age groups. Scand J Gastroenterol 37, 792-798.
20. Gill CIR, Heavey P, McConville E, et al. (2007) Effect of fecal water on an in vitro model of colonic mucosal barrier function. Nutr Cancer 57, 59-65.
21. Roediger WE (1982) Utilization of nutrients by isolated epithelial-cells of the rat colon. Gastroenterology 83, 424-429.
22. Wong JMW, de Souza R, Kendall CWC, et al. (2006) Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 40, 235-243.
23. Layden BT, Yalamanchi SK, Wolever TMS, et al. (2012) Negative association of acetate with visceral adipose tissue and insulin levels. Diabetes Metab Syndr Obes 5, 49-55.
24. Frost G, Sleeth ML, Sahuri-Arisoylu M, et al. (2014) The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun 5, 3611.
25. Kimura I, Inoue D, Maeda T, et al. (2011) Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 108, 8030-8035.
26. Al-Lahham S, Roelofsen H, Rezaee F, et al. (2012) Propionic acid affects immune status and metabolism in adipose tissue from overweight subjects. Eur J Clin Invest 42, 357-364.
27. Lin HV, Frassetto A, Kowalik EJ Jr, et al. (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLOS ONE 7, e35240.
28. Scheppach W, Sommer H, Kirchner T, et al. (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative-colitis. Gastroenterology 103, 51-56.
29. Fung KYC, Cosgrove L, Lockett T, et al. (2012) A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate. Br J Nutr 108, 820-831.
30. Fung KYC, Brierley GV, Henderson S, et al. (2011) Butyrateinduced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response. J Proteome Res 10, 1860-1869.
31. Shao YF, Gao ZH, Marks PA, et al. (2004) Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 101, 18030-18035.
32. Sauer J, Richter KK & Pool-Zobel BL (2007) Physiological concentrations of butyrate favorably modulate genes of oxidative and metabolic stress in primary human colon cells. J Nutr Biochem 18, 736-745.
33. Ploger S, Stumpff F, Penner GB, et al. (2012) Microbial butyrate and its role for barrier function in the gastrointestinal tract. Ann N Y Acad Sci 1258, 52-59.
34. Arpaia N, Campbell C, Fan X, et al. (2013) Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455.
35. De Vadder F, Kovatcheva-Datchary P, Goncalves D, et al. (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84-96.
36. Faber TA, Hopkins AC, Middelbos IS, et al. (2011) Galactoglucomannan oligosaccharide supplementation affects nutrient digestibility, fermentation end-product production, and large bowel microbiota of the dog. J Anim Sci 89, 103-112.
37. Theil PK, Jorgensen H, Serena A, et al. (2011) Products deriving from microbial fermentation are linked to insulinaemic response in pigs fed breads prepared from whole-wheat grain and wheat and rye ingredients. Br J Nutr 105, 373-383.
38. Van Immerseel F, Russell JB, Flythe MD, et al. (2006) The use of organic acids to combat Salmonella in poultry: A mechanistic explanation of the efficacy. Avian Pathol 35, 182-188.
39. Petry N, Egli I, Chassard C, et al. (2012) Inulin modifies the bifidobacteria population, fecal lactate concentration, and fecal pH but does not influence iron absorption in women with low iron status. Am J Clin Nutr 96, 325-331.
40. Linetzky Waitzberg D, Alves Pereira CC, Logullo L, et al. (2012) Microbiota benefits after inulin and partially hydrolized guar gum supplementation: A randomized clinical trial in constipated women. Nutr Hosp 27, 123-129.
41. Slavin J & Feirtag J (2011) Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects. Food Funct 2, 72-77.
42. Worthley DL, Le Leu RK, Whitehall VL, et al. (2009) A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr 90, 578-586.
43. Costabile A, Klinder A, Fava F, et al. (2007) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: A double-blind, placebo-controlled, crossover study. Br J Nutr 99, 110-120.
44. Costabile A, Fava F, Roytio H, et al. (2012) Impact of polydextrose on the faecal microbiota: A double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr 108, 471-481.
45. Timm DA, Stewart ML, Hospattankar A, et al. (2010) Wheat dextrin, psyllium, and inulin produce distinct fermentation patterns, gas volumes, and short-chain fatty acid profiles in vitro. J Med Food 13, 961-966.
46. Pylkas AM, Juneja LR & Slavin JL (2005) Comparison of different fibers for in vitro production of short chain fatty acids by intestinal microflora. J Med Food 8, 113-116.
47. Connolly ML, Lovegrove JA & Tuohy KM (2010) In vitro evaluation of the microbiota modulation abilities of different sized whole oat grain flakes. Anaerobe 16, 483-488.
48. Cuervo A, Salazar N, Ruas-Madiedo P, et al. (2013) Fiber from a regular diet is directly associated with fecal shortchain fatty acid concentrations in the elderly. Nutr Res 33, 811-816.
49. Kedia G, Vazquez JA, Charalampopoulos D, et al. (2009) In vitro fermentation of oat bran obtained by debranning with a mixed culture of human fecal bacteria. Curr Microbiol 58, 338-342.
50. Hughes SA, Shewry PR, Gibson GR, et al. (2008) In vitro fermentation of oat and barley derived b-glucans by human faecal microbiota. FEMS Microbiol Ecol 64, 482-493.
51. Laurentin A & Edwards CA (2004) Differential fermentation of glucose-based carbohydrates in vitro by human faecal bacteria-A study of pyrodextrinised starches from different sources. Eur J Nutr 43, 183-189.
52. Nordlund E, Aura AM, Mattila I, et al. (2012) Formation of phenolic microbial metabolites and short-chain fatty acids from rye, wheat, and oat bran and their fractions in the metabolical in vitro colon model. J Agric Food Chem 60, 8134-8145.
53. Nilsson A, Johansson E, Ekstrom L, et al. (2013) Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: A randomized cross-over study. PLOS ONE 8, e59985.
54. Van den Abbeele P, Venema K, van de Wiele T, et al. (2013) Different human gut models reveal the distinct fermentation patterns of arabinoxylan versus inulin. J Agric Food Chem 61, 9819-9827.
55. Hobden MR, Martin-Morales A, Guerin-Deremaux L, et al. (2013) In vitro fermentation of Nutriosew FB06, a wheat dextrin soluble fibre, in a continuous culture human colonic model system. PLOS ONE 8, e77128.
56. Noack J, Timm D, Hospattankar A, et al. (2013) Fermentation profiles of wheat dextrin, inulin and partially hydrolyzed guar gum using an in vitro digestion pretreatment and in vitro batch fermentation system model. Nutrients 5, 1500-1510.
57. Wang X & Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J Appl Bacteriol 75, 373-380.
58. Morrison DJ, Mackay WG, Edwards CA, et al. (2006) Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr 96, 570-577.
59. Lyra A, Lahtinen S, Tiihonen K, et al. (2010) Intestinal microbiota and overweight. Benef Microbes 1, 407-421.
60. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
61. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-Associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
62. Payne AN, Chassard C, Zimmermann M, et al. (2011) The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 1, e12.
63. Brinkworth GD, Noakes M, Clifton PM, et al. (2009) Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr 101, 1493-1502.
64. Schwiertz A, Taras D, Schafer K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195.
65. Tims S, Derom C, Jonkers DM, et al. (2013) Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J 7, 707-717.
66. Le Chatelier E, Nielsen T, Qin J, et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546.
67. Tiihonen K, Ouwehand AC & Rautonen N (2010) Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. Br J Nutr 103, 1070-1078.
68. Fleissner CK, Huebel N, Abd El-Bary MM, et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104, 919-929.
69. Borthakur A, Priyamvada S, Kumar A, et al. (2012) A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am J Physiol Gastrointest Liver Physiol 303, G1126-G1133.
70. Goncalves P, Catarino T, Gregorio I, et al. (2012) Inhibition of butyrate uptake by the primary bile salt chenodeoxycholic acid in intestinal epithelial cells. J Cell Biochem 113, 2937-2947.
71. Parrett AM, Edwards CA & Lokerse E (1997) Colonic fermentation capacity in vitro. Development during weaning in breast-fed infants is slower for complex carbohydrates than for sugars. Am J Clin Nutr 65, 927-933.
72. Sarbini SR, Kolida S, Gibson GR, et al. (2013) In vitro fermentation of commercial a-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr 109, 1980-1989.
73. Cani PD, Possemiers S, van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
74. Geurts L, Lazarevic V, Derrien M, et al. (2011) Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2, 149.
75. Geurts L, Neyrinck AM, Delzenne NM, et al. (2014) Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 5, 3-17.
76. de Goffau MC, Fuentes S, van den Bogert B, et al. (2014) Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia 57, 1569-1577.
77. de Goffau MC, Luopajarvi K, Knip M, et al. (2013) Fecal microbiota composition differs between children with b-cell autoimmunity and those without. Diabetes 62, 1238-1244.
78. Brown CT, Davis-Richardson AG, Giongo A, et al. (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6, e25792.
79. Wang W, Chen L, Zhou R, et al. (2014) Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 52, 398-406.
80. Machiels K, Joossens M, Sabino J, et al. (2014) A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275-1283.
81. Huda-Faujan N, Abdulamir AS, Fatimah AB, et al. (2010) The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4, 53-58.
82. Treem WR, Ahsan N, Shoup M, et al. (1994) Fecal shortchain fatty acids in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 18, 159-164.
83. Tjellström B, Högberg L, Stenhammar L, et al. (2012) Effect of exclusive enteral nutrition on gut microflora function in children with Crohns disease. Scand J Gastroenterol 47, 1454-1459.
84. Tjellström B, Högberg L, Stenhammar L, et al. (2013) Faecal short-chain fatty acid pattern in childhood coeliac disease is normalised after more than one years gluten-free diet. Microb Ecol Health Dis 2013, 24.
85. Tjellström B, Stenhammar L, Högberg L, et al. (2010) Screening-detected and symptomatic untreated celiac children show similar gut microflora-Associated characteristics. Scand J Gastroenterol 45, 1059-1062.
86. Tjellström B, Stenhammar L, Högberg L, et al. (2005) Gut microflora associated characteristics in children with celiac disease. Am J Gastroenterol 100, 2784-2788.
87. Bottcher MF, Nordin EK, Sandin A, et al. (2000) Microfloraassociated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy 30, 1590-1596.
88. Macfarlane S & Macfarlane GT (2003) Regulation of shortchain fatty acid production. Proc Nutr Soc 62, 67-72.
89. Mills E & ONeill LA (2014) Succinate: A metabolic signal in inflammation. Trends Cell Biol 24, 313-320.
90. Tannahill GM, Curtis AM, Adamik J, et al. (2013) Succinate is an inflammatory signal that induces IL-1b through HIF-1a. Nature 496, 238-242.
91. Ariake K, Ohkusa T, Sakurazawa T, et al. (2000) Roles of mucosal bacteria and succinic acid in colitis caused by dextran sulfate sodium in mice. J Med Dent Sci 47, 233-241.
92. Shiomi Y, Nishiumi S, Ooi M, et al. (2011) GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 17, 2261-2274.
93. Song WB, Lv YH, Zhang ZS, et al. (2009) Soluble intercellular adhesion molecule-1, d-lactate and diamine oxidase in patients with inflammatory bowel disease. World J Gastroenterol 15, 3916-3919.
94. Murray MJ, Gonze MD, Nowak LR, et al. (1994) Serum D(2)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am J Surg 167, 575-578.
95. Halperin ML & Kamel KS (1996) d-Lactic acidosis: Turning sugar into acids in the gastrointestinal tract. Kidney Int 49, 1-8.
96. Duzgun AP, Bugdayci G, Sayin B, et al. (2007) Serum D-lactate: A useful diagnostic marker for acute appendicitis. Hepatogastroenterology 54, 1483-1486.
97. Vernia P, Caprilli R, Latella G, et al. (1988) Fecal lactate and ulcerative colitis. Gastroenterology 95, 1564-1568.
98. Hove H & Mortensen PB (1995) Influence of intestinal inflammation (IBD) and small and large-bowel length on fecal short-chain fatty-Acids and lactate. Dig Dis Sci 40, 1372-1380.
99. Hove H, Holtug K, Jeppesen PB, et al. (1995) Butyrate absorption and lactate secretion in ulcerative colitis. Dis Colon Rectum 38, 519-525.
100. Marquet P, Duncan SH, Chassard C, et al. (2009) Lactate has the potential to promote hydrogen sulphide formation in the human colon. FEMS Microbiol Lett 299, 128-134.
101. Nyangale EP, Mottram DS & Gibson GR (2012) Gut microbial activity, implications for health and disease: The potential role of metabolite analysis. J Proteome Res 11, 5573-5585.
102. Windey K, De Preter V & Verbeke K (2012) Relevance of protein fermentation to gut health. Mol Nutr Food Res 56, 184-196.
103. Windey K, De Preter V, Louat T, et al. (2012) Modulation of protein fermentation does not affect fecal water toxicity: A randomized cross-over study in healthy subjects. PLOS ONE 7, e52387.
104. Birkett A, Muir J, Phillips J, et al. (1996) Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 63, 766-772.
105. Smith EA & Macfarlane GT (1996) Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 81, 288-302.
106. Swanson KS, Grieshop CM, Flickinger EA, et al. (2002) Fructooligosaccharides and lactobacillus acidophilus modify bowel function and protein catabolites excreted by healthy humans. J Nutr 132, 3042-3050.
107. Damen B, Cloetens L, Broekaert WF, et al. (2012) Consumption of breads containing in situ-produced arabinoxylan oligosaccharides alters gastrointestinal effects in healthy volunteers. J Nutr 142, 470-477.
108. Cloetens L, Broekaert WF, Delaedt Y, et al. (2010) Tolerance of arabinoxylan-oligosaccharides and their prebiotic activity in healthy subjects: A randomised, placebo-controlled crossover study. Br J Nutr 103, 703-713.
109. Lecerf JM, Depeint F, Clerc E, et al. (2012) Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108, 1847-1858.
110. Shinohara K, Ohashi Y, Kawasumi K, et al. (2010) Effect of apple intake on fecal microbiota and metabolites in humans. Anaerobe 16, 510-515.
111. Boler BM, Serao MC, Bauer LL, et al. (2011) Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr 106, 1864-1871.
112. Wutzke KD, Lotz M & Zipprich C (2010) The effect of preand probiotics on the colonic ammonia metabolism in humans as measured by lactose-[15N2]ureide. Eur J Clin Nutr 64, 1215-1221.
113. Gostner A, Blaut M, Schäffer V, et al. (2006) Effect of isomalt consumption on faecal microflora and colonic metabolism in healthy volunteers. Br J Nutr 95, 40-50.
114. Roediger W & Babidge W (1997) Human colonocyte detoxification. Gut 41, 731-734.
115. Collino S, Montoliu I, Martin FPJ, et al. (2013) Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism. PLOS ONE 8, e56564.
116. Patney NL, Mehrotra MP, Khanna HK, et al. (1976) Urinary indican excretion in cirrhosis of liver. J Assoc Physicians India 24, 291-295.
117. Patney NL, Saxena SK, Mehrotra MP, et al. (1977) Urinary indican in diabetes mellitus. J Indian Med Assoc 68, 94-97.
118. Renwick AG, Thakrar A, Lawrie CA, et al. (1988) Microbial amino-Acid metabolites and bladder cancer: no evidence of promoting activity in man. Hum Toxicol 7, 267-272.
119. Adams RF, Murray KE & Earl JW (1985) High levels of fecal para-cresol in a group of hyperactive children. Lancet ii, 1313-1313.
120. Pedersen G, Brynskov J & Saermark T (2002) Phenol toxicity and conjugation in human colonic epithelial cells. Scand J Gastroenterol 37, 74-79.
121. Mccall IC, Betanzos A, Weber DA, et al. (2009) Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol 241, 61-70.
122. Hughes R, Kurth MJ, McGilligan V, et al. (2008) Effect of colonic bacterial metabolites on Caco-2 cell paracellular permeability in vitro. Nutr Cancer 60, 259-266.
123. Meijers BK, Van Kerckhoven S, Verbeke K, et al. (2009) The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54, 891-901.
124. Roe DA (1971) Effects of methionine and inorganic sulfate on indole toxicity and indican excretion in rats. J Nutr 101, 645-654.
125. Smith EA & Macfarlane GT (1997) Dissimilatory amino acid metabolism in human colonic bacteria. Anaerobe 3, 327-337.
126. Wang L, Christophersen CT, Sorich MJ, et al. (2012) Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Dig Dis Sci 57, 2096-2102.
127. Visek WJ (1978) Diet and cell-growth modulation by ammonia. Am J Clin Nutr 31, S216-S220.
128. Blachier F, Mariotti F, Huneau JF, et al. (2007) Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences. Amino Acids 33, 547-562.
129. Macfarlane GT, Gibson GR & Cummings JH (1992) Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 72, 57-64.
130. Florin T, Neale G, Gibson GR, et al. (1991) Metabolism of dietary sulfate: Absorption and excretion in humans. Gut 32, 766-773.
131. Magee EA, Richardson CJ, Hughes R, et al. (2000) Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am J Clin Nutr 72, 1488-1494.
132. Leschelle X, Goubern M, Andriamihaja M, et al. (2005) Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfide. Biochim Biophys Acta 1725, 201-212.
133. Medani M, Collins D, Docherty NG, et al. (2011) Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm Bowel Dis 17, 1620-1625.
134. Pitcher MCL, Beatty ER & Cummings JH (2000) The contribution of sulphate reducing bacteria and 5-Aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut 46, 64-72.
135. Levine J, Ellis CJ, Furne JK, et al. (1998) Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 93, 83-87.
136. Moore J, Babidge W, Millard S, et al. (1998) Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 43, 162-165.
137. De Preter V, Arijs I, Windey K, et al. (2012) Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis. Inflamm Bowel Dis 18, 2371-2380.
138. Jowett SL, Seal CJ, Pearce MS, et al. (2004) Influence of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 53, 1479-1484.
139. Deplancke B & Gaskins HR (2003) Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 17, 1310-1312.
140. Attene-Ramos MS, Wagner ED & Plewa MJ (2006) Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 4, 9-14.
141. Attene-Ramos MS, Wagner ED, Gaskins HR, et al. (2007) Hydrogen sulfide induces direct radical-Associated DNA damage. Mol Cancer Res 5, 455-459.
142. Attene-Ramos MS, Nava GM, Muellner MG, et al. (2010) DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 51, 304-314.
143. Koehne CH & Dubois RN (2004) Cox-2 inhibition and colorectal cancer. Semin Oncol 31, 12-21.
144. Blachier F, Davila AM, Mimoun S, et al. (2010) Luminal sulfide and large intestine mucosa: friend or foe? Amino Acids 39, 335-347.
145. Mortensen PB & Clausen MR (1996) Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol 31, 132-148.
146. Makelainen HS, Makivuokko HA, Salminen SJ, et al. (2007) The effects of polydextrose and xylitol on microbial community and activity in a 4-stage colon simulator. J Food Sci 72, M153-M159.
147. Alles MS, Katan MB, Salemans JMJI, et al. (1997) Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch anal anastomosis. Am J Clin Nutr 66, 1286-1292.
148. Sakurazawa T & Ohkusa T (2005) Cytotoxicity of organic acids produced by anaerobic intestinal bacteria on cultured epithelial cells. J Gastroenterol 40, 600-609.
149. Kim E, Coelho D & Blachier F (2013) Review of the association between meat consumption and risk of colorectal cancer. Nutr Res 33, 983-994.
150. Del Rio D, Rodriguez-Mateos A, Spencer JPE, et al. (2013) Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18, 1818-1892.
151. DallAsta M, Calani L, Tedeschi M, et al. (2012) Identification of microbial metabolites derived from in vitro fecal fermentation of different polyphenolic food sources. Nutrition 28, 197-203.
152. Bolca S, Van de Wiele T & Possemiers S (2013) Gut metabotypes govern health effects of dietary polyphenols. Curr Opin Biotechnol 24, 220-225.
153. Tzounis X, Rodriguez-Mateos A, Vulevic J, et al. (2011) Prebiotic evaluation of cocoa-derived flavanols in healthy humans by using a randomized, controlled, double-blind, crossover intervention study. Am J Clin Nutr 93, 62-72.
154. Jaganath IB, Mullen W, Lean ME, et al. (2009) In vitro catabolism of rutin by human fecal bacteria and the antioxidant capacity of its catabolites. Free Radic Biol Med 47, 1180-1189.
155. Tuohy KM, Conterno L, Gasperotti M, et al. (2012) Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and/or fiber. J Agric Food Chem 60, 8776-8782.
156. Moco S, Martin FPJ & Rezzi S (2012) Metabolomics view on gut microbiome modulation by polyphenol-rich foods. J Proteome Res 11, 4781-4790.
157. Asano Y, Hiramoto T, Nishino R, et al. (2012) Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303, G1288-G1295.
158. Foster JA & McVey Neufeld K-A (2013) Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36, 305-312.
159. Rhee SH, Pothoulakis C & Mayer EA (2009) Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6, 306-314.
160. Gin H, Rigalleau V, Caubet O, et al. (1999) Effects of red wine, tannic acid, or ethanol on glucose tolerance in non-insulin-dependent diabetic patients and on starch digestibility in vitro. Metabolism 48, 1179-1183.
161. Henry CJ, Lightowler HJ, Newens KJ, et al. (2008) The influence of adding fats of varying saturation on the glycaemic response of white bread. Int J Food Sci Nutr 59, 61-69.
162. Bazzocco S, Mattila I, Guyot S, et al. (2008) Factors affecting the conversion of apple polyphenols to phenolic acids and fruit matrix to short-chain fatty acids by human faecal microbiota in vitro. Eur J Nutr 47, 442-452.
163. Fallani M, Amarri S, Uusijarvi A, et al. (2011) Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology 157, 1385-1392.
164. Zoetendal EG, Rajilic-Stojanovic M & De Vos WM (2008) High-Throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615.
165. Albenberg L & Wu GD (2014) Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology 146, 1564-1572.
166. Yap IKS, Brown IJ, Chan Q, et al. (2010) Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. J Proteome Res 9, 6647-6654.
167. Ou JH, Delany JP, Zhang M, et al. (2012) Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer 64, 34-40.
168. Macfarlane GT & Macfarlane S (2011) Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45, suppl., S120-S127.
169. Cummings JH, Hill MJ, Bone ES, et al. (1979) Effect of meat protein and dietary fiber on colonic function and metabolism. II. Bacterial metabolites in feces and urine. Am J Clin Nutr 32, 2094-2101.
170. Stephen AM, Wiggins HS & Cummings JH (1987) Effect of changing transit-Time on colonic microbial-metabolism in man. Gut 28, 601-609.
171. El Oufir L, Barry JL, Flourie B, et al. (2000) Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. Eur J Clin Nutr 54, 603-609.
172. Govers MJ, Gannon NJ, Dunshea FR, et al. (1999) Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: A study in pigs. Gut 45, 840-847.
173. Morita T, Kasaoka S, Hase K, et al. (1999) Psyllium shifts the fermentation site of high-Amylose cornstarch toward the distal colon and increases fecal butyrate concentration in rats. J Nutr 129, 2081-2087.
174. Zhao Y, Wu J, Li JV, et al. (2013) Gut microbiota composition modifies fecal metabolic profiles in mice. J Proteome Res 12, 2987-2999.
175. Washington N, Harris M, Mussellwhite A, et al. (1998) Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation. Am J Clin Nutr 67, 317-321.
176. Cherbut C (2003) Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 62, 95-99.
177. Kamath PS, Phillips SF, OConnor MK, et al. (1990) Colonic capacitance and transit in man: modulation by luminal contents and drugs. Gut 31, 443-449.
178. Jouet P, Moussata D, Duboc H, et al. (2013) Effect of shortchain fatty acids and acidification on the phasic and tonic motor activity of the human colon. Neurogastroenterol Motil 25, 943-949.
179. Dougal K, Harris PA, Edwards A, et al. (2012) A comparison of the microbiome and the metabolome of different regions of the equine hindgut. FEMS Microbiol Ecol 82, 642-652.
180. Wikoff WR, Anfora AT, Liu J, et al. (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106, 3698-3703.
181. Verbeke K, Ferchaud-Roucher V, Preston T, et al. (2010) Influence of the type of indigestible carbohydrate on plasma and urine short-chain fatty acid profiles in healthy human volunteers. Eur J Clin Nutr 64, 678-684.
182. de Graaf AA & Venema K (2007) Gaining insight into microbial physiology in the large intestine: A special role for stable isotopes. Adv Microb Physiol 53, 73-168, 313-314.
183. Osswald K, Becker TW, Grimm M, et al. (2000) Inter-And intra-individual variation of faecal water-genotoxicity in human colon cells. Mutat Res 472, 59-70.
184. Bosworth D & Venitt S (1986) Testing human fecal extracts for genotoxic activity with the SOS chromotest: The importance of controlling for fecal enzyme activity. Mutagenesis 1, 143-149.
185. De Kok TMCM & van Maanen JMS (2000) Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 463, 53-101.
186. Mower HF, Ichinotsubo D, Wang LW, et al. (1982) Fecal mutagens in two Japanese populations with different colon cancer risks. Cancer Res 42, 1164-1169.
187. Gratz SW, Wallace RJ & El-Nezami HS (2011) Recent perspectives on the relations between fecal mutagenicity, genotoxicity and diet. Front Pharmacol 2, 4.
188. Klinder A, Karlsson PC, Clune Y, et al. (2007) Fecal water as a non-invasive biomarker in nutritional intervention: comparison of preparation methods and refinement of different endpoints. Nutr Cancer 57, 158-167.
189. Karlsson PC, Huss U, Jenner A, et al. (2005) Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds. J Nutr 135, 2343-2349.
190. Nordling MM, Glinghammar B, Karlsson PC, et al. (2003) Effects on cell proliferation, activator protein-1 and genotoxicity by fecal water from patients with colorectal adenomas. Scand J Gastroenterol 38, 549-555.
191. Morrow DMP, Ryan MP & McGlynn H (1996) An in vitro model to assess tumour promotor activity. Br J Cancer 74, 68.
192. Gill CIR, McDougall GJ, Glidewell S, et al. (2010) Profiling of phenols in human fecal water after raspberry supplementation. J Agric Food Chem 58, 10389-10395.
193. Jovov B, Wills NK & Lewis SAA (1991) spectroscopic method for assessing confluence of epithelial-cell cultures. Am J Physiol 261, C1196-C1203.
194. Ramakers JD, Volman JJ, Biorklund M, et al. (2007) Fecal water from ileostomic patients consuming oat b-glucan enhances immune responses in enterocytes. Mol Nutr Food Res 51, 211-220.
195. Lapre JA & VanderMeer R (1992) Diet-induced increase of colonic bile-Acids stimulates lytic activity of fecal water and proliferation of colonic cells. Carcinogenesis 13, 41-44.
196. Haza AI, Glinghammar B, Grandien A, et al. (2000) Effect of colonic luminal components on induction of apoptosis in human colonic cell lines. Nutr Cancer 36, 79-89.
197. Glinghammar B, Holmberg K & Rafter J (1999) Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis 20, 969-976.
198. Glinghammar B & Rafter J (2001) Colonic luminal contents induce cyclooxygenase 2 transcription in human colon carcinoma cells. Gastroenterology 120, 401-410.
199. Zeng HW & Davis CD (2003) Down-regulation of proliferating cell nuclear antigen gene expression occurs during cell cycle arrest induced by human fecal water in colonic HT-29 cells. J Nutr 133, 2682-2687.
200. Pool-Zobel BL (2005) Inulin-Type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr 93, S73-S90.
201. Klinder A, Forster A, Caderni G, et al. (2004) Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination. Nutr Cancer 49, 144-155.
202. Glei M, Habermann N, Osswald K, et al. (2005) Assessment of DNA damage and its modulation by dietary and genetic factors in smokers using the comet assay: A biomarker model. Biomarkers 10, 203-217.
203. Wu WT, Cheng HC & Chen HL (2011) Ameliorative effects of konjac glucomannan on human faecal b-glucuronidase activity, secondary bile acid levels and faecal water toxicity towards Caco-2 cells. Br J Nutr 105, 593-600.
204. Walton GE, van den Heuvel EGHM, Kosters MHW, et al. (2012) A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 107, 1466-1475.
205. Le Gall G, Noor SO, Ridgway K, et al. (2011) Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 10, 4208-4218.
206. Martin FPJ, Collino S & Rezzi S (2011) 1H NMR-based metabonomic applications to decipher gut microbial metabolic influence on mammalian health. Magn Reson Chem 49, Suppl. S1, S47-S54.
207. Martin FPJ, Rezzi S, Pere-Trepat E, et al. (2009) Metabolic effects of dark chocolate consumption on energy, gut microbiota, and stress-related metabolism in free-living subjects. J Proteome Res 8, 5568-5579.
208. Cheng Y, Xie GX, Chen TL, et al. (2012) Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 11, 1354-1363.
209. Qiu YP, Cai GX, Su MM, et al. (2010) Urinary metabonomic study on colorectal cancer. J Proteome Res 9, 1627-1634.
210. Qiu Y, Cai G, Su M, et al. (2009) Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLCQTOFMS. J Proteome Res 8, 4844-4850.
211. Tulipani S, Llorach R, Jauregui O, et al. (2011) Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption. J Proteome Res 10, 5047-5058.
212. Calvani R, Miccheli A, Capuani G, et al. (2010) Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. Int J Obes 34, 1095-1098.
213. Suhre K, Meisinger C, Doring A, et al. (2010) Metabolic footprint of diabetes: A multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5, e13953.
214. Ponnusamy K, Choi JN, Kim J, et al. (2011) Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 60, 817-827.
215. Ktsoyan ZA, Beloborodova NV, Sedrakyan AM, et al. (2011) Profiles of microbial fatty acids in the human metabolome are disease-specific. Front Microbiol 1, 148.
216. Martin FPJ, Sprenger N, Montoliu I, et al. (2010) Dietary modulation of gut functional ecology studied by fecal metabonomics. J Proteome Res 9, 5284-5295.
217. Fava F, Gitau R, Griffin BA, et al. (2013) The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome at-risk population. Int J Obes 37, 216-223.
218. Seiber JN, Molyneux RJ & Schieberle P (2014) Targeted metabolomics: A new section in the Journal of Agricultural and Food Chemistry. J Agric Food Chem 62, 22-23.
219. Martin FPJ, Sprenger N, Yap IKS, et al. (2009) Panorganismal gut microbiome-host metabolic crosstalk. J Proteome Res 8, 2090-2105.
220. Ndagijimana M, Laghi L, Vitali B, et al. (2009) Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H nuclear magnetic resonance spectroscopy. Int J Food Microbiol 134, 147-153.
221. Vitali B, Ndagijimana M, Cruciani F, et al. (2010) Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 10, 4.
222. De Preter V, Ghebretinsae AH, Abrahantes JC, et al. (2011) Impact of the synbiotic combination of Lactobacillus casei Shirota and oligofructose-enriched inulin on the fecal volatile metabolite profile in healthy subjects. Mol Nutr Food Res 55, 714-722.
223. De Preter V, Joossens M, Ballet V, et al. (2013) Metabolic profiling of the impact of oligofructose-enriched inulin in Crohns disease patients: A double-blinded randomized controlled trial. Clin Transl Gastroenterol 4, e30.
224. Zoetendal EG, Raes J, van den Bogert B, et al. (2012) The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 6, 1415-1426.
225. Faust K & Raes J (2012) Microbial interactions: from networks to models. Nat Rev Microbiol 10, 538-550.
226. Bron PA, van Baarlen P & Kleerebezem M (2012) Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10, 66-78.
227. Arumugam M, Raes J, Pelletier E, et al. (2011) Enterotypes of the human gut microbiome. Nature 473, 174-180.
228. De Filippo C, Cavalieri D, Di Paola M, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691-14696.
229. Guerin-Danan C, Andrieux C, Popot F, et al. (1997) Pattern of metabolism and composition of the fecal microflora in infants 10 to 18 months old from day care centers. J Pediatr Gastroenterol Nutr 25, 281-289.
230. Siigur U, Ormisson A & Tamm A (1993) Faecal short-chain fatty acids in breast-fed and bottle-fed infants. Acta Paediatr 82, 536-538.
231. Holscher HD, Faust KL, Czerkies LA, et al. (2012) Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. JPEN J Parenter Enteral Nutr 36, 95S-105S.
232. Norin E, Midtvedt T & Bjorksten B (2004) Development of faecal short-chain fatty acid pattern during the first year of life in Estonian and Swedish infants. Microb Ecol Health Dis 16, 8-12.
233. Bakker-Zierikzee AM, Alles MS, Knol J, et al. (2005) Effects of infant formula containing a mixture of galacto-And fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 94, 783-790.
234. Samuelsson U & Ludvigsson J (2004) The concentrations of short-chain fatty acids and other microflora-Associated characteristics in faeces from children with newly diagnosed type 1 diabetes and control children and their family members. Diabet Med 21, 64-67.
235. Parrett AM & Edwards CA (1997) In vitro fermentation of carbohydrate by breast fed and formula fed infants. Arch Dis Child 76, 249-253.
236. Whelan K, Judd PA, Preedy VR, et al. (2005) Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr 135, 1896-1902.
237. Lewis SJ & Heaton KW (1997) Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41, 245-251.
238. Reimer RA, Pelletier X, Carabin IG, et al. (2012) Faecal short chain fatty acids in healthy subjects participating in a randomised controlled trial examining a soluble highly viscous polysaccharide versus control. J Hum Nutr Diet 25, 373-377.
239. Fernando WMU, Hill JE, Zello GA, et al. (2010) Diets supplemented with chickpea or its main oligosaccharide component raffinose modify faecal microbial composition in healthy adults. Beneficial Microbes 1, 197-207.
240. McOrist AL, Miller RB, Bird AR, et al. (2011) Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr 141, 883-889.
241. Nemoto H, Kataoka K, Ishikawa H, et al. (2012) Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci 57, 2955-2964.
242. McOrist AL, Abell GC, Cooke C, et al. (2008) Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. Br J Nutr 100, 138-146.
243. Hylla S, Gostner A, Dusel G, et al. (1998) Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 67, 136-142.
244. Benassi-Evans B, Clifton P, Noakes M, et al. (2010) Highprotein/high red meat and high-carbohydrate weight-loss diets do not differ in their effect on faecal water genotoxicity tested by use of the WIL2-NS cell line and with other biomarkers of bowel health. Mutat Res 703, 130-136.
245. Ling WH & Hanninen O (1992) Shifting from a conventional diet to an uncooked vegan diet reversibly alters fecal hydrolytic activities in humans. J Nutr 122, 924-930.
246. Patel KP, Luo FJG, Plummer NS, et al. (2012) The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores. Clin J Am Soc Nephrol 7, 982-988.
247. De Preter V, Geboes K, Verbrugghe K, et al. (2004) The in vivo use of the stable isotope-labelled biomarkers lactose-[15N]ureide and [2H4]tyrosine to assess the effects of proand prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 92, 439-446.
248. De Preter V, Coopmans T, Rutgeerts P, et al. (2007) Influence of long-Term administration of lactulose and Saccharomyces boulardii on the colonic generation of phenolic compounds and on different gastro-intestinal parameters. J Am Coll Nutr 25, 541-549.
249. De Preter V, Vanhoutte T, Huys G, et al. (2007) Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292, G358-G368.
250. Cloetens L, De Preter V, Swennen K, et al. (2008) Doseresponse effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr 27, 512-518.
251. Heavey PM, Savage SAH, Parrett A, et al. (2003) Proteindegradation products and bacterial enzyme activities in faeces of breast-fed and formula-fed infants. Br J Nutr 89, 509-515.
252. Clarke JM, Topping DL, Christophersen CT, et al. (2011) Butyrate esterified to starch is released in the human gastrointestinal tract. Am J Clin Nutr 94, 1276-1283.
253. Bianchi MA, Scazzina F, Del Rio D, et al. (2010) Ability of a high-Total antioxidant capacity diet to increase stool weight and bowel antioxidant status in human subjects. Br J Nutr 104, 1500-1507.
254. Alakomi HL, Puupponen-Pimia R, Aura AM, et al. (2007) Weakening of Salmonella with selected microbial metabolites of berry-derived phenolic compounds and organic acids. J Agric Food Chem 55, 3905-3912.
255. Ko HS, Jin RD, Krishnan HB, et al. (2009) Biocontrol ability of Lysobacter antibioticus HS124 against phytophthora blight is mediated by the production of 4-hydroxyphenylacetic acid and several lytic enzymes. Curr Microbiol 59, 608-615.
256. Roowi S, Stalmach A, Mullen W, et al. (2010) Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans. J Agric Food Chem 58, 1296-1304.
257. Okello EJ, Leylabi R & McDougall GJ (2012) Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites. Food Funct 3, 651-661.
258. Ni N, Choudhary G, Li M, et al. (2008) Pyrogallol and its analogs can antagonize bacterial quorum sensing in Vibrio harveyi. Bioorg Med Chem Lett 18, 1567-1572.
259. Taguri T, Tanaka T & Kouno I (2006) Antibacterial spectrum of plant polyphenols and extracts depending upon hydroxyphenyl structure. Biol Pharm Bull 29, 2226-2235.
260. Jackman KA, Woodman OL & Sobey CG (2007) Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights. Curr Med Chem 14, 2824-2830.
261. Ishimi Y (2009) Soybean isoflavones in bone health. Forum Nutr 61, 104-116.
262. Davis CD & Milner JA (2009) Gastrointestinal microflora, food components and colon cancer prevention. J Nutr Biochem 20, 743-752.
263. Selma MV, Espin JC & Tomas-Barberan FA (2009) Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem 57, 6485-6501.
264. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, et al. (2006) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54, 1611-1620.
265. Del Rio D, Borges G & Crozier A (2010) Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br J Nutr 104, S67-S90.
266. DellAgli M, Galli GV, Bulgari M, et al. (2010) Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar J 9, 208.
267. Cervantes-Laurean D, Schramm DD, Jacobson EL, et al. (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17, 531-540.